![]()
Dosage ; 10mg TID with or after food. Usual maintenance: 5-20mg TID
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Adalat | Bayer Schering Pharma | Bayer East Africa Ltd. | 20mg | 60 | Tablet | per tablet | KES 3,509.60 |
| Adalat | Bayer Schering Pharma | Bayer East Africa Ltd. | 30mg | 30 | Tablet | per tablet | KES 2,192.09 |
| Adalat | Bayer Schering Pharma | Bayer East Africa Ltd. | 60mg | 30 | Tablet | per tablet | KES 3,025.05 |
| Adalat | Bayer Schering Pharma | Bayer East Africa Ltd. | 60mg | 28 | Tablet | per tablet | KES 2,827.15 |
| Calcigard | Torrent Pharmaceuticals Ltd. | Medox Pharmaceuticals Ltd. | 20mg | 100 | Tablet | per tablet | KES 200 |
| Cardia Retard | Nabros Pharma Products | Galaxy Pharmaceuticals Ltd | 20mg | 30 | Tablet | per tablet | KES 180 |
| Carditas | Intas Pharmaceuticals Ltd | Unicorn Pharma (K) Ltd. | 20mg | 1000 | Tablet | per tablet | KES 850 |
| Depin-E Retard | Zydus Cadila Healthcare | C.Mehta & Co Ltd. | 20mg | 100 | Tablet | per tablet | KES 350.00 |
| Depin-E Retard | Zydus Cadila Healthcare | C.Mehta & Co Ltd. | 20mg | 1000 | Tablet | per tablet | KES 550.00 |
| Epilat | E.I.P.C.O. | Zadchem Pharmacy Ltd. | 20mg | 20 | Tablet | per tablet | KES 240 |
| Nicardia CD | Unique Pharmaceuticals Laboratories | Surgilinks Ltd. | 30mg | 30 | Tablet | per tablet | KES 1914.65 |
| Nicardin | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 20mg | 60 | Tablet | per tablet | KES 90.00 |
| Nicardin | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 20mg | 1000 | Tablet | per tablet | KES 800.00 |
| Nicardin | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 20mg | 100 | Tablet | per tablet | KES 120.00 |
| Nifed | West Coast Pharmaceuticals Works Ltd | Ray Pharmaceuticals Ltd | 20mg | 100 | Tablet | per tablet | KES 781.25 |
| Nifed | West Coast Pharmaceuticals Works Ltd | Ray Pharmaceuticals Ltd | 20mg | 1000 | Tablet | per tablet | KES 2233.25 |
| Nifedi-Denk | E-Denk OHG | Omaera Pharmaceuticals Ltd | 10mg | 100 | Tablet | per tablet | KES 847.00 |
| Nifedi-Denk | E-Denk OHG | Omaera Pharmaceuticals Ltd | 20mg | 100 | Tablet | per tablet | KES 1,365.00 |
| Nifelat R | Remedica Ltd. | Twokay Chemicals Ltd | 20mg | 100 | Tablet | per tablet | KES 500.00 |
| Nifelat Retard | Cipla Ltd. | Lords Healthcare Ltd. | 20mg | 30 | Tablet | per tablet | KES 293.25 |
| Nifelong LA | Prism Life Sciences | Galaxy Pharmaceuticals Ltd | 20mg | 100 | Tablet | per tablet | KES 300 |
| Zenusin | Mepha | Goodman Agencies Ltd | 125ml | Mouthwash | KES 130 | ||
| Nifelong ER | Prism Life Sciences | Galaxy Pharmaceuticals Ltd | 20mg | 100 | Tablet | per tablet | KES 180.00 |
| Nifedipine | Macleods Pharmaceuticals Ltd. | Sai Pharmaceuticals Ltd. | 20mg | 100 | Tablet | per tablet | KES 211.00 |
| Zenusin SR | Acino – Switzerland | Goodman Agencies Ltd | 20mg | 30 | Tablet | per tablet | KES 960.00 |
| Nifedipine More info | |
|---|---|
| Mode Of Action | Calcium channel blocker |
| Drug Indication | Stable angina and hypertension |
| Precautions | Irreversible renal failure and hypotension, poor cardiac reserve, HF and severe aortic stenosis, withdrawal in case of worsening ischaemic pain, severe hypotension, pregnancy and lactation, avoid grape fruit juice. |
| Contra-Indications | Pregnancy, cardiogenic shock, advanced aortic stenosis, porphyria. |
| Side Effects | Headache, lethargy, flushing, GI disturbances, peripheral oedema, hypotension, palpitation, perspiration, aggravation of angina, allergic reactions, gynaecomastia, gingival hyperplasia. |
| Dosage | Nifedipine 10mg cap: indicated for angina, raynauds phenomenon and hypertension. Dose: 10mg TID with or after food. Usual maintenance: 5-20mg TID. For immediate effect in angina bite into capsule and retain liquid in mouth or swallow.Nifedine 20mg retard: Stable angina and hypertension.Nifedipine 30mg: Hypertension and angina, 30mg OD (max. 90mg OD). |
| Pregnancy Category | Category C |
| Pregnancy Category Description | Drugs which, owing to their pharmacological effects, or may be suspected of causing detrimental effects on human foetus or neonates without causing malfunctions. These effects may be reversible |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |
| Drug Sub-Category | Calcium-channel blockers
Combinations ; |